The results showed that 2nd-gen 4-1BBζ-CAR took a longer time to eradicate leukemia blasts than did 3rd-gen 4-1BBζ-CAR-IL18 and this difference was further expanded at a lower dose (Fig. 4a and Extended Data Fig. 12). Here, IL18 is linked to leukemia.